Immediate Impact

1 by Nobel laureates 56 standout
Sub-graph 1 of 23

Citing Papers

Depletion of tumor associated macrophages enhances local and systemic platelet-mediated anti-PD-1 delivery for post-surgery tumor recurrence treatment
2022 Standout
Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer
2022 Standout
4 intermediate papers

Works of Astrid Schott being referenced

Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma
2008
A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas
2008
and 1 more

Author Peers

Author Last Decade Papers Cites
Astrid Schott 209 172 7 73 8 415
Sharon Space 178 194 97 128 5 459
T. Christopher Windham 203 178 14 43 14 435
Laura K. Nolden 233 130 21 33 7 393
Alba Mineo 207 110 8 97 13 442
Aaron J. Schueneman 155 179 35 58 8 372
Wei‐Shu Wang 211 245 5 36 12 443
Catherine Geh 229 188 6 36 7 504
Ruirong Yuan 201 200 13 37 11 457
So Young Rha 150 181 15 43 7 428
Qurish K. Mohemmad 301 125 2 27 5 474

All Works

Loading papers...

Rankless by CCL
2026